IPO Listed — 28 Nov 2025
Listing Price: ₹730 (+23.1% vs ₹593)
Sudeep Pharma IPO Review
Sudeep Pharma IPO has been reviewed by 2 analysts, and the overall consensus is Apply — carrying a score of 67. Out of the 2 analysts who have covered this IPO, 1 recommend subscribing while 1 advises caution or avoidance — reflecting a broadly positive view from the analyst community.
The issue is priced in the band of ₹563-593 per share , with a minimum application size of 25 shares (minimum investment of approximately ₹14,825 at the upper band) . Subscription ran from 21 Nov 2025 to 25 Nov 2025. Scroll down for the full analyst breakdown and analyst-wise verdicts.
General Review
Sudeep Pharma IPO bidding started from Nov 21, 2025 and ended on Nov 25, 2025. The allotment for Sudeep Pharma IPO was finalized on Nov 26, 2025. Sudeep Pharma IPO will list on BSE, NSE with a tentative listing date fixed as Nov 28, 2025
Disclaimer: This review is an AI summary derived from the reviews of all analysts.
Table of Contents
Recommend Subscribe
Based on 2 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Sudeep Pharma IPO?
Based on analyst coverage tracked on this page, the overall verdict for Sudeep Pharma IPO is Apply. Out of 2 analysts who have reviewed this IPO, 1 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 67 mean for Sudeep Pharma IPO?
The score of 67 is an aggregate of all analyst ratings tracked for Sudeep Pharma IPO. A score in this range reflects mixed views — some analysts are positive while others are cautious. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Sudeep Pharma IPO?
Sudeep Pharma IPO listed on November 28, 2025 at ₹730 , against the issue price of ₹593 — a gain of +23.1% (₹137 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Sudeep Pharma IPO?
Sudeep Pharma IPO was priced at ₹563-593 per share. The minimum lot size is 25 shares, making the minimum investment approximately ₹14,825 at the upper end of the price band. Subscription ran from 21 Nov 2025 to 25 Nov 2025.
Explore Sudeep Pharma IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!